Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bayer: Levitra on-demand effective in ED patients

Bayer: Levitra on-demand effective in ED patients

30th July 2008

Bayer has announced the publication of a new study in the European Urology journal showing that Levitra ( vardenafil, HCI) on-demand is an effective treatment for men with erectile dysfunction (ED) shortly after radical nerve-sparing prostatectomy.

The study from Bayer Schering Pharma assessed the efficacy and tolerability of Levitra taken once-nightly against Levitra PRN taken on demand and placebo in patients following nerve-sparing, radical retropubic prostatectomy.

Trials were conducted at 87 centres across Europe, North America and South Africa involving 445 men for up to 13 months.

Bayer notes despite the continuous evolution of the nerve-sparing radical prostatectomy technique used to treat prostate cancer patients, the risk of developing ED remains significant.

Professor Francesco Montorsi from the University Vita Salute San Raffaele, said: “The results show that Levitra taken on demand effectively treats erectile dysfunction immediately and reliably after prostatectomy.”

He added that this study will give new information on the most efficient use of PDE5 inhibitors in men with ED caused by this type of surgery.

In March 2008, Bayer Shering Pharma presented the results of a new Levitra study showing the treatment works well in men with dyslipidemia.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.